Thus, the role of HIF-1α in laryngeal carcinoma radioresistance and whether inhibition of HIF-1α expression can improve radiosensitivity of laryngeal carcinoma require further evaluation. This evidence concerns the gene HIF1A and laryngeal carcinoma.